Linking statins and lipids in Parkinson's disease

Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database

(2017) Guodong Liu et al.   MOVEMENT DISORDERS

Statin therapy prevents the onset of Parkinson disease in patients with diabetes

(2016) Kun-Der Lin et al.   ANNALS OF NEUROLOGY

Statin use and risk of Parkinson’s disease: A meta-analysis

(2016) Zhiguo Sheng et al.   BEHAVIOURAL BRAIN RESEARCH

Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis

(2016) Katsiaryna Bykov et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

(2015) Xuemei Huang et al.   MOVEMENT DISORDERS

Discontinuation of statin therapy associates with Parkinson disease: A population-based study

(2013) Y.-C. Lee et al.   NEUROLOGY

Prospective Study of Statin Use and Risk of Parkinson Disease

(2012) Xiang Gao   ARCHIVES OF NEUROLOGY

Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies

(2012) Krishna Undela et al.   JOURNAL OF NEUROLOGY

Statins and neuroprotection

(2010) W. Gibson Wood et al.   Annals of the New York Academy of Sciences

Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan

(2010) Yoshihiro Miyake et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies

(2009) Andrew O. Koob et al.   EXPERIMENTAL NEUROLOGY

Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

(2009) A. Ghosh et al.   JOURNAL OF NEUROSCIENCE

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

(2008) Xuemei Huang et al.   MOVEMENT DISORDERS

Total cholesterol and the risk of Parkinson disease

(2008) G. Hu et al.   NEUROLOGY